The phrase "we previously submitted" is a correct and usable phrase in written English.
You can use it to refer to something that was sent or presented to someone in the past. For example, "We previously submitted our bid for the project, but the deadline has since passed."
David Wood, legal counsel for Initiative for a Competitive Online Marketplace (ICOMP), which campaigns for Microsoft and other complainants, said: "We can confirm we were contacted by the commission and asked to provide non-confidential versions of documents we had previously submitted.
We tested previously submitted CSF samples for SAFV, reviewed the patients' medical records, and sequenced the viruses isolated.
Recently, the editors of this journal kindly suggested that a brief editorial on the subject of Copyright might be more useful than the comprehensive article on the subject that we had previously submitted.
We keep copies of previously submitted transcripts for two years from the date of your previous application; you will still need to submit any new or updated transcripts.
We may have copies of previously submitted GRE or TOEFL scores submitted within the past 5 years; please email [email protected] to confirm.
In the previously submitted manuscript, we had demonstrated that (1) sorafenib inhibits glutamate release; (2) sorafenib-induced death could be inhibited by β-ME co-treatment, which implies that death is due to the blockade of cystine uptake; and (3) sorafenib upregulates CHAC1 expression, a feature associated with the ER stress response observed upon system xc- inhibition.
For these reasons we provided both types of maps in the previously submitted version of the article and we are happy to provide an additional gradient analysis for the best frequency/rate approach in the current manuscript.
We acknowledge that the p values reported in the manuscript previously submitted are dependent on the study sample size, and may not provide sufficient support of measurement reliability.
In the previously submitted iteration of this manuscript to eLife we have shown that the response to amplitude modulation rate shows similarly broad tuning curves.
We performed an adaptation of a Markov-based cost-effectiveness model previously submitted by the manufacturers of apixaban (Bristol-Myers Squibb and Pfizer) to NICE in the UK including local epidemiological and clinical data.
